Biotechnology ציבורי
[search 0]
עוד

Download the App!

show episodes
 
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management
 
Loading …
show series
 
DrugPatentWatch has been ranked the “Best Biopharmaceuticals Commercial Business Intelligence Platform” by Global Health & Pharma News This award is dedicated to honoring the innovation, determination and outstanding levels of…The post DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform appeared first on DrugPat…
 
DrugPatentWatch’s Custom Market Surveillance provides you with a robust platform to monitor your business opportunities from every angle. You’re monitoring your business, but you’re too busy to sift through data.…The post DrugPatentWatch Custom Market Surveillance appeared first on DrugPatentWatch - Make Better Decisions.…
 
Before the passage of the Biologic Patent Transparency Act DrugPatentWatch’s biologic patent data was cited as a reason why the law should not be passed. Thankfully, the Act advanced, and…The post Updating the DrugPatentWatch Biologics Module appeared first on DrugPatentWatch - Make Better Decisions.…
 
This paper was originally published by Andreas H. Göller, Lara Kuhnke, Floriane Montanari, Anne Bonin, Sebastian Schneckener, Antoniuster Laak, Jörg Wichard, Mario Lobell, and Alexander Hillisch in Drug Discovery Today…The post Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades appeared first on DrugPatentWatc…
 
This paper was originally published by Md. Imtiaz Hasan et al in Journal of Biosciences and Medicines under a Creative Commons Attribution 4.0 International License Abstract Development of generic drug product…The post Development of Generic Drug Products by Pharmaceutical Industries Considering Regulatory Aspects: A Review appeared first on DrugPa…
 
This is my talk from the 14th Annual Portfolio Planning and Partnership for Generic Conference. I discuss: Identifying generic entry opportunities at the earliest stages Discovering opportunities that avoid litigation…The post Generic Portfolio Management, Partnering with Brands, and Staying Competitive appeared first on DrugPatentWatch - Make Bett…
 
I’ll be leading a workshop on generic portfolio management, and also giving a talk, at the 14th annual Marcus Evans event on Portfolio Planning and Partnerships for Generics. The event…The post Workshop and lecture on generic portfolio management appeared first on DrugPatentWatch - Make Better Decisions.…
 
I’ll be leading a workshop on generic portfolio management, and also giving a talk, at the 14th annual Marcus Evans event on Portfolio Planning and Partnerships for Generics. The event…The post Upcoming workshop on generic portfolio management appeared first on DrugPatentWatch - Make Better Decisions.…
 
Come join me and Wendi Lau from Abbvie as we participate in an interactive roundtable discussion on pharmaceutical portfolio management. We’ll be sharing our expertise and best practices for strategic…The post DrugPatentWatch and Abbvie discuss Pharmaceutical Portfolio Management appeared first on DrugPatentWatch - Make Better Decisions.…
 
When it comes to pricing generic drugs, there are a number of factors that come into play. In countries without drug price regulations, the pricing is based largely on profitability.…The post Strategies for Pricing Generic Drugs appeared first on DrugPatentWatch - Make Better Decisions.על ידי DrugPatentWatch
 
Want insights into the biggest revenue-changing events? ➤ Get Your Certificate Today By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay…The post Get Your Certificate in Generic and Branded Drug Lifecycle Management appeared first on DrugPatentWatch - Make Be…
 
How Much Time Are You Wasting on Manual, Repetitive Tasks? Stop wasting time on repetitive reports: Contact us Are your staff burdened with manual, repetitive tasks, like data collection, and…The post Stop paying your staff to make repetitive reports appeared first on DrugPatentWatch - Make Better Decisions.…
 
New DrugPatentWatch module connects excipients and drug patents In response to user requests, DrugPatentWatch has added a new database of excipients (inactive ingredients) in drugs, and integrated it with our…The post Connecting Excipients with Drug Patents – New DrugPatentWatch module appeared first on DrugPatentWatch - Make Better Decisions.…
 
Are you tired of having to navigate complicated contracts to access the information you need? Let DrugPatentWatch free you from weeks of negotiating complex contracts and let you focus on…The post Say ‘NO’ to Bad Contracts appeared first on DrugPatentWatch - Make Better Decisions.על ידי DrugPatentWatch
 
DrugPatentWatch was featured in a recent article by Inc. Magazine. In their coverage of Mark Cuban’s new pharma company, they cited our published interview where Mark Cuban Sounds off on Drug Prices.…The post DrugPatentWatch featured in Inc Magazine appeared first on DrugPatentWatch - Make Better Decisions.…
 
This article was originally published by Abdrhman Mahmoud Gamil in World Journal of Advanced Research and Reviews, 2020, 08(03), 337–349 under a Creative Commons Attribution Liscense 4.0. Abstract Procurement is…The post Pharmaceutical procurement practice aspects appeared first on DrugPatentWatch - Make Better Decisions.…
 
This article was originally published by Andreas Bender and Isidro Cortes-Ciriano in Drug Discovery Today under a Creative Commons license. Although artificial intelligence (AI) has had a profound impact on…The post Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not t…
 
This article was originally published by Sajna T. in Management Insight, 16(1):38-40 under a creative commons license. Abstract Business enterprises are an important organ of society. The impact of a…The post Indian Pharma—Some Challenges and Acceptances appeared first on DrugPatentWatch - Make Better Decisions.…
 
Mark Schultz and Jaci McDole recently used DrugPatentWatch to complete a report on recent trends in the latest editions of the world health organization essential medicines list. Some of their key…The post Essential Medicines and Patents appeared first on DrugPatentWatch - Make Better Decisions.על ידי DrugPatentWatch
 
PREVEN EMERGENCY CONTRACEPTIVE KIT (ethinyl estradiol; levonorgestrel) Teva branded pharmPatent: 6,156,742Expiration: Dec 5, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence…The post Drug Patent Expirations for the Week of November 29, 2020 appeared first on DrugPatentWatch - Make B…
 
Annual Drug Patent Expirations for ENTEREG Entereg is a drug marketed by Cubist Pharms and is included in one NDA. It is available from one supplier. There are four patents…The post New patent expiration for Cubist Pharms drug ENTEREG appeared first on DrugPatentWatch - Make Better Decisions.על ידי DrugPatentWatch
 
We prefer simple flat-rate unrestricted subscriptions — we’ll work on your terms, and with your favorite subscription contract template, to find a solution that fits. If your colleagues would like to…The post Thinking of signing your company up for DrugPatentWatch? appeared first on DrugPatentWatch - Make Better Decisions.…
 
Here is a copy of the talk I gave at the recent Marcusevans 13th Portfolio Management and Pipeline Optimization for Generics. I cover: How to find and evaluate generic entry…The post Finding and Evaluating Generic Drug Market Entry Opportunities appeared first on DrugPatentWatch - Make Better Decisions.…
 
This article not subject to U.S. Copyright. Published 2019 by the American Chemical Society. Noel T. Southall Abstract We report our experience working with the US Food and Drug Administration…The post Freedom of Information Act Access to an Investigational New Drug Application appeared first on DrugPatentWatch - Make Better Decisions.…
 
I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th Portfolio Management & Pipeline Optimization for Generics on September 30th.…The post Finding and Evaluating Generic Market Entry Opportunities appeared first on DrugPatentWatch - Make Better Decisions.…
 
This is a guest post by Shamil Gizatullin, Gowling WLG (International) Inc. shamil.gizatullin@gowlingwlg.com Although it has become harder to obtain patent-term extensions for drugs, pesticides or agricultural chemicals, a careful…The post Getting the most out of pharmaceutical patent-term extensions in Russia appeared first on DrugPatentWatch - Ma…
 
Don’t wait until the end of the year to start looking for alternatives to your existing business intelligence providers. DrugPatentWatch can help you replace or supplement your current solutions with:…The post Switching to DrugPatentWatch appeared first on DrugPatentWatch - Make Better Decisions.על ידי DrugPatentWatch
 
Using data from DrugPatentWatch Fred Ledley and his research group at the Center for Integration of Science and Industry at Bentley University published a paper investigating the involvement of government…The post Government as the First Investor in Biopharmaceutical Innovation appeared first on DrugPatentWatch - Make Better Decisions.…
 
In a recent Bloomberg Law article DrugPatentWatch data is used to show a decrease in patent litigation. This likely means fewer generic entrants and less opportunities for consumers to enjoy…The post Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs appeared first on DrugPatentWatch - Make Better Decisions.…
 
This paper was originally published by Melek Simsek, Berrie Meijer, Adriaan A. van Bodegraven, Nanne K.H. de Boer, and Chris J.J. Mulder in Drug Discovery Today under a Creative Commons…The post Finding hidden treasures in old drugs: the challenges and importance of licensing generics appeared first on DrugPatentWatch - Make Better Decisions.…
 
This article was originally published by Mahendra Saini, Nikhita Parihar, Shankar Lal Soni, and Vandana Sharma in the Asian Journal of Pharmaceutical Research and Development. 2020; 8(4): 194-212 under an…The post Drug Repurposing: An Overview appeared first on DrugPatentWatch - Make Better Decisions.…
 
When drug patents expire, billions of dollars in revenues can disappear overnight as competitors enter the market. Accordingly, many investors focus on drug patents when evaluating drug companies. But, there…The post Investing in Drug Companies? Here are 6 Vital Non-Patent Factors to Consider appeared first on DrugPatentWatch - Make Better Decision…
 
Just because a drug has received FDA approval does not mean that it is available in the marketplace. But, why would a company go through all the trouble and expense…The post Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will hit the Market appeared first on DrugPatentWatch - Make Better Decisions.…
 
I’ll be giving a talk on Finding and Evaluating Market Entry Opportunities for a Better ROI at the upcoming 13th Portfolio Management & Pipeline Optimization for Generics from September 30th…The post Finding and Evaluating Market Entry Opportunities for a Better ROI appeared first on DrugPatentWatch - Make Better Decisions.…
 
The USPTO Office of the Chief Economist has releases a comprehensive set of patent litigation data files for public use. The Patent Litigation Dataset has been updated as of December…The post Free Patent Litigation Docket Reports Data appeared first on DrugPatentWatch - Make Better Decisions.על ידי DrugPatentWatch
 
The FDA Orange Book, or Approved Drug Products with Therapeutic Equivalence Evaluations, is the definitive source to link drugs with the patents that protect them. Over the years we’ve had…The post Free Orange Book PDF Library from DrugPatentWatch appeared first on DrugPatentWatch - Make Better Decisions.…
 
This article was originally published by Syed Sauban Ghani in Eclética Química under a Creative Commons license. ABSTRACT As scientific community worldwide is publishing a huge number of research articles…The post A comprehensive review of database resources in chemistry appeared first on DrugPatentWatch - Make Better Decisions.…
 
This article was originally published by Mohammed M. Alshehri and Mahmoud M. E. Mudawi in the Journal of Pharmaceutical Research International under the terms of the Creative Commons Attribution License.…The post Common Drugs with Effective Off-Label Uses appeared first on DrugPatentWatch - Make Better Decisions.…
 
Check out this Bloomberg Law article where DrugPatentWatch shows how the number of patent challenges is increasing, while the number of challengers of each patent is also increasing. Why might this…The post DrugPatentWatch and Bloomberg: Are there too many generic patent challenges? appeared first on DrugPatentWatch - Make Better Decisions.…
 
Check out the latest issue of Lab Manager where I discuss my interest in informatics, the complexities of informatics for today’s scientists, and some of the tools available. https://www.labmanager.com/ask-the-expert/trends-in-informatics-22895The post Lab Manager Ask the Expert appeared first on DrugPatentWatch - Make Better Decisions.…
 
In response to customer requests, we’ve built some new tools for formulary management. You can preview these tools at: Recent Generic Drug Launches Upcoming 180-Day Patent Challenge Exclusivity Expirations Anticipate…The post Customer Success: Formulary Management appeared first on DrugPatentWatch - Make Better Decisions.…
 
Let DrugPatentWatch build custom dashboards and reports to take the load off of your team. We can ensure the production of accurate, objective, and timely intelligence to help you quickly…The post Automated Reports and Custom Dashboards appeared first on DrugPatentWatch - Make Better Decisions.על ידי DrugPatentWatch
 
This article was originally published by Hermann Mucke & Peter Mucke in Future Drug Discovery under a Attribution-NonCommercial-NoDerivatives 4.0 Unported License. https://doi.org/10.4155/fdd-2020-0001. Drug developers require access to scientific information in…The post Drug repurposing patent documents vs peer review: patent information comes mor…
 
Loading …

מדריך עזר מהיר

זכויות יוצרים 2021 | מפת אתר | מדיניות פרטיות | תנאי השירות
Google login Twitter login Classic login